ELI LILLY AND COMPANY for ELI LILLY AND COMPANY
What was lobbied
12 issue areas, each in the filer's own words, with who lobbied on it and where.
Consumer Issues/Safety/Products CSP
China Counterfeiting and Regulatory, Global Anti-Counterfeiting, Anti-Counterfeiting Trade Agreement (ACTA)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEANNIE SALO New | Legislative Assistant, Foreign Relations Committee |
Food Industry (safety, labeling, etc.) FOO
Child Nutrition Reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSE SEVCIK | — |
Animals ANI
Veterinary Antibotics (S 619 & HR 1549)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSE SEVCIK | — |
Trade (domestic/foreign) TRD
Veterinary Medicine Market Access; Czech Republic (market access & pricing reform); European Union (Pharmaceutical Package legislation); Finland (IP); Germany (pricing & health care reform); Italy (pricing & health care reform); Norway (IP & market access); Poland (market access); Slovakia (IP & market access); Sweden (pricing & health care reform); United Kingdon (pricing & health care reform); Anti-Counterfeiting Trade Agreement; Latin America Free Trade Agreements; (CONTINUED ON NEXT PAGE) Canada (Pharmaceutical Market Access and Drug Safety Act - S 242 & access restrictions & IP); Cuba (omnibus bill & sanctions); Mexico (IP & market access); Brazil (IP & market access); Algeria (IP & access restrictions); Tunisia (IP & access restrictions); Egypt (IP); Saudia Arabia (IP & access restrictions); Peru (FTA Implementation); Argentina (IP & access restrictions); Chili (IP); Turkey (IP & access restrictions); Russia (IP & WTO accession); Israel (IP); Columbia (IP); South Africa (access restrictions); Japan (pricing & regulatory reform); China (anti-counterfeiting & pricing reform); Taiwan (pricing reform & IP); Korea (pricing reform); Thailand (CL); Indonesia (investment decree); Philippines (pricing reform);
| Lobbyist | Covered position, as disclosed |
|---|---|
| KERN BRIGGS | — |
| HARRISON C COOK | — |
| DESIREE FILIPPONE | — |
| JEANNIE SALO New | Legislative Assistant, Foreign Relations Committee |
| JESSE SEVCIK | — |
| DAVID TALBOT | — |
Taxation/Internal Revenue Code TAX
Off-shore tax (HR 1265), Repatriation (HR 1), American Recovery and Reinvestment Act (S 1)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAY BONITT | — |
| JESSIE BRAIRTON | — |
| SEAN DONOHUE | — |
| JESSE PRICE | — |
Copyright/Patent/Trademark CPT
Patent Reform (S 515 & HR 1260); Finland (IP); Norway (IP & market access); Slovakia (IP & market access); China (counterfeiting); Global Anti-Counterfeiting, Anti-Counterfeiting Trade Agreement; World Health Organization; Canada (IP & market access); Mexico (IP & market access); Brazil (IP & market access); Algeria (IP & market access); Tunisia (IP & market access); Egypt (IP); Saudia Arabia (IP & market access); Argentina (IP & market access); Chili (IP); (CONTINUED NEXT PAGE) Turkey (IP & market access); Russia (IP & WTO accession); Israel (IP); Columbia (IP); China (anti-counterfeiting); Taiwan (IP & pricing reform);
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRUCE ARTIM | — |
| JAY BONITT | — |
| KERN BRIGGS | — |
| HARRISON C COOK | — |
| JESSE PRICE | — |
| JEANNIE SALO New | Legislative Assistant, Foreign Relations Staff |
| DAVID TALBOT | — |
Health Issues HCR
American Recovery and Reinvestment Act of 2009 (S 1), Omnibus Appropriations Act (HR 1105), SCHIP (HR 2), Follow-on Biologics (S 726, HR 1427, HR 1548), CER-Stimulus (HR 1), Wyden Health Care Reform (S 391), Health Care Reform (general); Sweden (health care reform); United Kingdom (health care reform); Issues Related to Tuberculosis Funding; Patient Safety Related to Online Sales of Counterfeits and Diversion in the US
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRUCE ARTIM | — |
| JAY BONITT | — |
| JESSIE BRAIRTON | — |
| KERN BRIGGS | — |
| SEAN DONOHUE | — |
| DESIREE FILIPPONE | — |
| JESSE PRICE | — |
| JEANNIE SALO New | Legislative Assistant, Foreign Relations Committee |
| SONYA SOTAK ELLING | — |
Foreign Relations FOR
Issues Related to Tuberculosis Funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| DESIREE FILIPPONE | — |
Medicare/Medicaid MMM
Medicaid Rebate Increase, Medicaid rebate applied to Medicaid Managed Care Plans, Medicaid rebate applied to Part D, 340B Expansion (HR 444), Transparency
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSIE BRAIRTON | — |
| JESSE PRICE | — |
| SONYA SOTAK ELLING | — |
Medical/Disease Research/Clinical Labs MED
21st Century Cancer Access to Life-Saving Early Detection, Research and Treatment (S 717), Fair Medicaid Drug Payment and Genetic Information Nondiscription Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN DONOHUE | — |
| SONYA SOTAK ELLING | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.